Loading data for AFIB — first visit, this takes a few seconds.
Acutus Medical, Inc. (AFIB)
OTC Markets OTCPK: AFIB
· Real-Time Price · USD
0.00
+0.00 (n/a)
At close: Sep 04, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Acutus Medical, Inc. (AFIB) Stock Price, Analysis & Data
No data available
| Bid | 0.03 |
| Market Cap | 2.99K |
| Revenue (ttm) | 20.2M |
| Net Income (ttm) | -4.54M |
| 5.79 | |
| -0.15 | |
| n/a | |
| 0 | |
| P/B (ttm) | 0.00 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 0.04 |
| Volume | 10,000 |
| Avg. Volume (20D) | 3,553 |
| Open | 0.00 |
| Previous Close | 0.00 |
| Day's Range | 0.00 - 0.00 |
| 52-Week Range | 0.00 - 0.01 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About AFIB
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acut...
Industry Medical Devices
Sector Healthcare
IPO Date Aug 6, 2020
Employees 85
Stock Exchange OTC Markets OTCPK
Ticker Symbol AFIB
Website https://www.acutusmedical.com
Financial Performance
In 2024, Acutus Medical's revenue was 20.16M, an increase of 181.37% compared to the previous year's 7.16M. Earnings were -9.55M, a decrease of -88.31%.
Financial StatementsEarnings Surprise
Acutus Medical has released their quarterly earnings on Nov 8, 2023:
- Revenue of $7.13M misses estimates by $0, with Infinity% YoY growth.
- EPS of -0.52 exceeds estimates by 0.04, with 25.71% YoY growth.